Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 17 analysts that cover Ionis Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $67.88, which forecasts a 10.71% increase in the stock price over the next year. The lowest target is $39 and the highest is $96.

Price Target: $67.88 (+10.71%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$39	$67.88	$65	$96
Change	-36.39%	+10.71%	+6.01%	+56.57%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	7	7	7	5	6	7
Buy	4	4	4	5	5	6
Hold	6	6	5	3	4	3
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	0	1
Total	18	18	17	14	15	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luca Issi RBC Capital	RBC Capital	Buy Maintains $70 → $80	Buy	Maintains	$70 → $80	+30.47%	Sep 4, 2025
David Lebowitz Citigroup	Citigroup	Strong Buy Maintains $69 → $84	Strong Buy	Maintains	$69 → $84	+37.00%	Sep 3, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Strong Sell Maintains $40 → $45	Strong Sell	Maintains	$40 → $45	-26.61%	Sep 3, 2025
Kostas Biliouris BMO Capital	BMO Capital	Hold → Buy Upgrades $40 → $70	Hold → Buy	Upgrades	$40 → $70	+14.16%	Sep 3, 2025
Gena Wang Barclays	Barclays	Buy Maintains $58 → $78	Buy	Maintains	$58 → $78	+27.21%	Sep 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

876.48M

Increased by 24.30%

from 705.14M

Revenue Next Year

933.46M

Increased by 6.50%

from 876.48M

EPS This Year

-2.57

from -3.04

EPS Next Year

-2.94

from -2.57

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	729.26M	810.46M	587.37M	787.65M	705.14M	876.48M	933.46M
Revenue Growth	-35.04%	11.13%	-27.53%	34.10%	-10.48%	24.30%	6.50%
EPS	-3.18	-0.20	-1.90	-2.56	-3.04	-2.57	-2.94
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	30	30

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	1,000.0M	1.5B
Avg	876.5M	933.5M
Low	817.7M	673.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	41.8%	66.7%
Avg	24.3%	6.5%
Low	16.0%	-23.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.50	-1.60
Avg	-2.57	-2.94
Low	-2.86	-4.38

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.